Join host Eoin Tabb for a special dispatch episode recorded live from the ISOPP 2025 Symposium in Victoria, BC. Get your 'audio delegate bag' with key insights from Day 1, covering:
- Implementing bispecific antibodies (BiTEs) like teclistamab and talquetamab in multiple myeloma, focusing on community administration and managing toxicities (CRS, ICANS, infections, oral/skin/nail issues).
- The practice-changing impact of blinatumomab in frontline B-ALL based on the E1910 trial.
- Innovations in hazardous drug safety using Closed System Transfer Devices (CSTDs) and automation.
- SMART strategies for managing toxicities (ILD, neutropenia, nausea, neuropathy) of ADCs like T-DXd, T-DM1, and Sacituzumab Govitecan in metastatic breast cancer.
